Adherence to doxycycline for uncomplicated genitourinary chlamydia: A prospective observational study
Abstract Objectives Since 2020, the Center for Disease Control and Prevention (CDC) no longer recommends single‐dose azithromycin as first‐line therapy for uncomplicated genitourinary chlamydia, advising instead a 7‐day course of doxycycline. Our study investigates self‐reported adherence to the new...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2024-04-01
|
| Col·lecció: | Journal of the American College of Emergency Physicians Open |
| Accés en línia: | https://doi.org/10.1002/emp2.13137 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|